CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 4 Open-market sale Chief Executive Officer sold 12,094 shares at an average $82.40 ($996,521)
- 4 Shares withheld for taxes Chief Financial Officer gave up 295 shares (to pay taxes)
- 4/A Open-market sale Director sold 5,000 shares at an average $66.94 ($334,715)
- 4 Open-market sale Director sold 1,295 shares at $77.35 ($100,168)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale Director sold 5,000 shares at an average $66.94 ($334,715)
- 4 Grant or award Director acquired 923 shares (grant or award)
- 4 Grant or award Director acquired 923 shares (grant or award)
- 4 Grant or award Director acquired 1,292 shares (grant or award)
- 4 Grant or award Director acquired 923 shares (grant or award)
- 4 Grant or award Director acquired 923 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 34 · 669 filings